USE OF THE INDICATION OF THE EXPRESSION OF SPLICE VARIANTS OF GENE 21 FOR THE DIAGNOSIS AND TREATMENT OF TUMOUR DISEASES

Details for Australian Patent Application No. 2002317169 (hide)

Owner MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN

Inventors BRETT, Dave; KEMMNER, Wolfgang

Pub. Number AU-A-2002317169

PCT Number PCT/DE02/02001

PCT Pub. Number WO2002/097119

Priority 101 26 472.0 31.05.01 DE

Filing date 30 May 2002

Wipo publication date 9 December 2002

International Classifications

C12Q 001/00 Measuring or testing processes involving enzymes or micro-organisms

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 101 26 472.0 31.05.01 DE

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002317169

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317170-DEVICE FOR PRODUCING A COMBUSTIBLE GAS MIXTURE

2002317168-Energy absorption device for the front face of rail vehicles